News-opinions
Merck KGaA Revenues Up; Outlook Positive for 2010
 |
German Merck KGaA's total group revenues in 2009 were up 2.1% to € 7,747 million. A strong performance in the company's Pharmaceuticals sector - 6.5% increase in revenues - served to offset a 9% decline in Chemicals. Merck recorded a 5.9% increase in total revenues to € 2,029 million in Q4 2009.
Chairman Dr. Karl-Ludwig Kley said he was satisfied with his company's results, considering the difficult economic climate in 2009. In a press release, Kley said it will be crucial that the positive recovery trend remains stable. Merck's outlook reflects this expectation - the company said it assumes that total group revenues should increase by 3% to 7% and that the operating result could grow by 20% to 30%."
Related Articles :
- Q1 2012: Merck Total Revenues Increase 3.2% to €2.6 Billion
- Merck Serono Sets Up Biotech Incubator in Israel
- Newron Agrees Parkinson's Drug Deal with Zambon
- Merck KGaA to Cut Costs, Jobs Despite Record Revenues in 2011
- BASF Buys Merck's Electrolytes Business
Keywords : full-year results Merck KGaA Q4
Company Homepage- Legal
- Help
- Participate
- Related Publications
Reader comments (0)